Is it time to reassess standard toxicity and patient reported outcomes methodologies for the adjuvant use of immune checkpoint inhibitors (ICIs)?
- DOI
- 10.1016/j.annonc.2026.09.003
- Published
- 2026 Sep 15
- Container
- Annals of oncology : official journal of the European Society for Medical Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2026.09.003,
title = {Is it time to reassess standard toxicity and patient reported outcomes methodologies for the adjuvant use of immune checkpoint inhibitors (ICIs)?},
author = {Nally E and Lyon J and Regan M and Rini B and Voss M and Atkins MB and Powles T and McDermott DF},
year = {2026},
journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
doi = {10.1016/j.annonc.2026.09.003},
url = {https://doi.org/10.1016/j.annonc.2026.09.003}
}RIS
TY - JOUR TI - Is it time to reassess standard toxicity and patient reported outcomes methodologies for the adjuvant use of immune checkpoint inhibitors (ICIs)? AU - Nally E AU - Lyon J AU - Regan M AU - Rini B AU - Voss M AU - Atkins MB AU - Powles T AU - McDermott DF PY - 2026 JO - Annals of oncology : official journal of the European Society for Medical Oncology DO - 10.1016/j.annonc.2026.09.003 UR - https://doi.org/10.1016/j.annonc.2026.09.003 ER -
APA
E, N., J, L., M, R., B, R., M, V., MB, A., T, P., & DF, M. (2026). Is it time to reassess standard toxicity and patient reported outcomes methodologies for the adjuvant use of immune checkpoint inhibitors (ICIs)?. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2026.09.003
Source records
- pubmed · retrieved 2026-09-25T07:07:20.090Z